Effect of the use of dapagliflozin in diuresis, natriuriesis, and in ultrafiltration and peritoneal elimination of sodium in patients with refractory heart failure: DAPA-DP study

Effect of the use of dapagliflozin in diuresis, natriuriesis, and in ultrafiltration and peritoneal elimination of sodium in patients with refractory heart failure: DAPA-DP study

Abstract Background Peritoneal dialysis (PD) has emerged as an effective technique for managing refractory heart failure (HF) in patients unresponsive to diuretics. Previous meta-analyses have demonstrated significant reductions in hospitalization days and improvements in cardiac function among pati...

Full description

Bibliographic Details
Main Authors: Marco Montomoli, Camila Solano Rivera, Miguel Gonzalez Rico, Rafael De la Espriella Juan, Gonzalo Nuñez Marín, Maria Jesús Puchades Montesa, Jose Luis Gorriz Teruel
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Renal Replacement Therapy
Online Access:https://doi.org/10.1186/s41100-024-00594-4

Internet

https://doi.org/10.1186/s41100-024-00594-4

Similar Items